Arsenic exposure and toxicology: A historical perspective

Toxicological Sciences

Volumn 123, Issue 2, 2011, Pages 305-332

  Hughes, Michael F ^a   Beck, Barbara D ^b   Chen, Yu ^c   Lewis, Ari S ^b   Thomas, David J ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b GRADIENT   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Cancer; Exposure

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; ARSPHENAMINE; CARBON; HYDROGEN; METHYLTRANSFERASE; OXYGEN; PHOSPHATE; POTASSIUM ARSENITE; REACTIVE OXYGEN METABOLITE; SULFUR; UNCLASSIFIED DRUG;

ABSCESS; AIR POLLUTION; ARTICLE; ASTHMA; BLADDER CANCER; BREAST CANCER; CARCINOGENICITY; CATALYSIS; CELL PROLIFERATION; CHOREA; COVALENT BOND; DNA METHYLATION; DNA REPAIR; ECZEMA; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; FOOD CONTAMINATION; GASTROINTESTINAL SYMPTOM; GENOTOXICITY; HUMAN; LUNG CANCER; MALARIA; NONHUMAN; OCCUPATIONAL HAZARD; OXIDATION; OXIDATIVE STRESS; PROMYELOCYTIC LEUKEMIA; PSORIASIS; SIGNAL TRANSDUCTION; SKIN CANCER; SOIL POLLUTION; SYPHILIS; ULCER; WATER CONTAMINATION;

ANIMALS; ARSENIC POISONING; ARSENICALS; CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL EXPOSURE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; TOXICOLOGY;

ANIMALIA;

EID: 80052798438     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr184     Document Type: Article

References (327)

1. Agusa, T., Iwata, H., Fujihara, J., Kunito, T., Takeshita, H., Minh, T. B., Trang, P. T., Viet, P. H., and Tanabe, S. (2009). Genetic polymorphisms in AS3MT and arsenic metabolism in residents of the Red River Delta, Vietnam. Toxicol. Appl. Pharmacol. 236, 131-141.
2. Ahmad, S., Kitchin, K. T., and Cullen, W. R. (2000). Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382, 195-202.
3. Ahsan, H., Chen, Y., Kibriya, M. G., Slavkovich, V., Parvez, F., Jasmine, F., Gamble, M. V., and Graziano, J. H. (2007). Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16, 1270-1278.
4. Ahsan, H., Chen, H., Parvez, F., Zablotska, L., Argo, M., Hussain, I., Monotaj, H., Levy, D., Cheng, Z., Stankovich, V., et al. (2006). Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am. J. Epidemiol. 163, 1138-1148.
5. Andrew, A. S., Burgess, J. L., Meza, M. M., Demidenko, E., Waugh, M., Hamilton, J. W., and Karagas, M. R. (2006). Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ. Health Perspect. 114, 1193-1198.
6. Andrew, A. S., Jewell, D. A., Mason, R. A., Whitfield, M. L., Moore, H. J., and Karagas, M. R. (2008). Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ. Health Perspect. 116, 524-531.
7. Andrew, A. S., Karagas, M. R., and Hamilton, J. W. (2003). Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water. Int. J. Cancer 104, 263-268.
8. Andrew, A. S., Mason, R. A., Memoli, V., and Duell, E. J. (2009). Arsenic activates EGFR pathway signaling in the lung. Toxicol. Sci. 109, 350-357.
9. Andrewes, P., DeMarini, D. M., Funasaka, K., Wallace, K., Lai, V. W. M., Sun, H., Cullen, W. R., and Kitchin, K. T. (2004). Do arsenosugars pose a risk to human health? The comparative toxicities of a trivalent and pentavalent arsenosugar. Environ. Sci. Technol. 38, 4140-4148.
10. Antman, K. H. (2001). Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6(Suppl. 2), 1-2.
11. Aposhian, H. V. (1997). Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37, 397-419.
12. Argos, M., Kalra, T., Rathouz, P. J., Chen, Y., Pierce, B., Parvez, F., Islam, T., Ahmed, A., Rakibuz-Zaman, M., Hasan, R., et al. (2010). Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 376, 252-258.
13. Arnold, L. L., Cano, M., John, M. S., Eldan, M., van Gemert, M., and Cohen, S. M. (1999). Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 20, 2171-2179.
14. Arnold, L. L., Eldan, M., Nyska, A., van Gemert, M., and Cohen, S. (2006). Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and B6C3F1 mice. Toxicology 223, 82-100.
15. Arnold, L. L., Eldan, M., van Gemert, M., Capca, C., and Cohen, S. M. (2003). Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice. Toxicology 190, 197-219.
16. ATSDR. (2007a). CERCLA Priority List of Hazardous Substances for 2007 Available at: http://www.atsdr.cdc.gov/cercla/07list.html. Accessed June 9, 2011.
17. ATSDR. (2007b). Toxicological Profile for Arsenic. Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Atlanta, GA. Available at: http://www.atsdr.cdc.gov/ToxProfiles/tp2.pdf. Accessed July 27, 2011.
18. Barchowsky, A., Dudek, E. J., Treadwell, M. D., and Wetterhahn, K. E. (1996). Arsenic induces oxidant stress and NF-κβ activation in cultured aortic endothelial cells. Free Radic. Biol. Med. 21, 783-790.
19. Barchowsky, A., Roussel, R. R., Klei, L. R., James, P. E., Ganju, N., Smith, K. R., and Dudek, E. J. (1999). Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 159, 65-75.
20. Baroni, C., van Esch, G. J., and Saffiotti, U. (1963). Carcinogenesis tests of two inorganic arsenicals. Arch. Environ. Health 7, 54-60.
21. Bartrip, P. (1992). A pennruth of arsenic for rat poison: the Arsenic Act, 1851 and the prevention of secret poisoning. Med. Hist. 36, 53-69.
22. Basu, A., Mahata, J., Gupta, S., and Giri, A. K. (2001). Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat. Res. 488, 171-194.
23. Bates, M. N., Rey, O. A., Biggs, M. L., Hopenhayn, C., Moore, L. E., Kalman, D., Steinmaus, C., and Smith, A. H. (2004). Case-control study of bladder cancer and exposure to arsenic in Argentina. Am. J. Epidemiol. 159, 381-389.
24. Beckman, G., Beckman, L., and Nordenson, I. (1977). Chromosome aberrations in workers exposed to arsenic. Environ. Health Perspect. 19, 145-146.
25. Benbrahim-Tallaa, L., Waterland, R. A., Styblo, M., Achanzar, W. E., Webber, M. M., and Waalkes, M. P. (2005). Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol. Appl. Pharmacol. 206, 288-289.
26. Bode, A. M., and Dong, Z. (2002). The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit. Rev. Oncol. Hematol. 24, 5-24.
27. Borak, J., and Hosgood, H. D. (2007). Seafood arsenic: implications for human risk assessment. Regul. Toxicol. Pharmacol. 47, 204-212.
28. Boutwell, R. K. (1963). A carcinogenicity evaluation of potassium arsenite and arsanilic acid. J. Agric. Food Chem. 11, 381-385.
29. Braman, R. S., and Foreback, C. C. (1973). Methylated forms of arsenic in the environment. Science 182, 1247-1249.
30. Buchet, J. P., and Lauwerys, R. (1985). Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57, 125-129.
31. Buchet, J. P., Lauwerys, R., and Roels, H. (1981). Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48, 71-79.
32. Buck, A. H., and Stedman, T. L. (1904). In A Reference Handbook of the Medical Sciences Embracing the Entire Range of Scientific and Practical Medicine and Allied Science, Vol. III. William Wood and Company, New York, NY.
33. Burns, F. J., Uddin, A. N., Wu, F., Nadas, A., and Rossman, T. G. (2004). Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ. Health Perspect. 112, 559-602.
34. Byron, W. R., Bierbower, G. W., Brouwer, J. B., and Hansen, W. H. (1967). Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol. Appl. Pharmacol. 10, 132-147.
35. Caudill, D. S. (2009). Arsenic and old chemistry: images of mad alchemists, experts attacking experts, and the crisis in forensic science. Boston Univ. J. Sci. Tech. Law 15, Villanova Law/Public Policy Research Paper no.2009-13. Available at: http:///ssrn.com/abstract=140275. Accessed on December 3, 2010.
36. Cavigelli, M., Li, W. W., Lin, A., Su, B., Yoshioka, K., and Karin, M. (1996). The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15, 6269-6279.
37. Challenger, F. (1947). Biological methylation. Sci. Prog. 35, 396-416.
38. Challenger, F. (1951). Biological methylation. Adv. Enzymol. Relat. Subj. Biochem. 12, 429-491.
39. Chanda, S., Dasgupta, U. B., Guhamazumder, D., Gupta, M., Chaudhuri, U., Lahiri, S., Das, S., Ghosh, N., and Chatterjee, D. (2006). DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol. Sci. 89, 431-437.
40. Chen, C. J., Kuo, T. L., and Wu, M. M. (1988). Arsenic and cancers. Lancet 1(8583), 414-415.
41. Chen, C. L., Chiou, H. Y., Hsu, L. I., Hsueh, Y. M., Wun, M. M., Wang, Y. H., and Chen, C. J. (2010). Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan. Cancer Epidemiol. Biomarkers Prev. 19, 101-110.
42. Chen, Y., Graziano, J. H., Parvez, F., Liu, M., Slavkovich, V., Kalra, T., Argos, M., Islam, T., Ahmed, A., Rakibuz-Zaman, M., et al. (2011). Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. doi: 10.1136/bmj.d2431.
43. Chen, Y., Hall, M., Graziano, J. H., Slavkovich, V., van Geen, A., Parvez, F., and Ahsan, H. (2007). A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol. Biomarkers Prev. 17, 207-213.
44. Chen, Y., Parvez, F., Gamble, M., Islam, T., Ahmed, A., Argos, M., Graziano, J. H., and Ahsan, H. (2009). Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol. Appl. Pharmacol 239, 184-192.
45. Ch'i, I. C., and Blackwell, R. Q. (1968). A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am. J. Epidemiol. 88, 7-24.
46. Chiou, H. Y., Chiou, S. T., Hsu, Y. H., Chou, Y. L., Tseng, C. H., Wei, M. L., and Chen, C. J. (2001). Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasisendemic area in northeastern Taiwan. Am. J. Epidemiol. 153, 411-418.
47. Chowdhury, U. K., Zakharyan, R. A., Hernandez, A., Avram, M. D., Kopplin, M. J., and Aposhian, H. V. (2006). Glutathione-S-transferaseomega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicol. Appl. Pharmacol. 216, 446-457.
48. Chung, C. J., Hsueh, Y. M., Bai, C. H., Huang, Y. K., Huang, Y. L., Yang, M. H., and Chen, C. J. (2009). Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer. Cancer Causes Control 20, 1653-1661.
49. Clements, R., Tree, H. G., Ewing, P. L., and Emerson, G. A. (1951). Conversion by tissues of inorganic arsenicals to forms not recoverable by the usual assay methods. Tex. Rep. Biol. Med. 9, 27-33.
50. Cohen, S. M., Arnold, L. L., Eldan, M., Lewis, A. S., and Beck, B. D. (2006). Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36, 99-133.
51. Cohen, S. M., Arnold, L. L., Uzvolgyi, E., St. John, M., Yamamoto, S., Lu, X., and Le, X. C. (2002). Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15, 1150-1157.
52. Cohen, S. M., and Ellwein, L. B. (1990). Cell proliferation in carcinogenesis. Science 249, 1007-1011.
53. Cohen, A., King, H., and Strangeways, W. I. (1931). CCCCXXI. Trypanocidal action and chemical constitution. Part X. Arylthioarsinates. J. Chem. Soc. 3043-3057.
54. Cohen, S. M., Yamamoto, S., Cano, M., and Arnold, L. L. (2001). Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicol. Sci. 59, 68-74.
55. Crane, R. K., and Lipmann, R. (1953). The effect of arsenate on aerobic phosphorylation. J. Biol. Chem. 201, 235-243.
56. Crecelius, E. A. (1977). Changes in the chemical speciation of arsenic following ingestion by man. Environ. Health Perspect. 19, 147-150.
57. Cullen, W. R. (2008). Is Arsenic an Aphrodisiac? The Sociochemistry of an Element. Royal Society of Chemistry, Cambridge, U.K.
58. Cullen, W. R., and Bentley, R. (2005). The toxicity of trimethylarsine: an urban myth. J. Environ. Monit. 7, 11-15.
59. De Chaudhuri, S., Ghosh, P., Sarma, N., Majumdar, P., Sau, T. J., Basu, S., Roychoudhury, S., Ray, K., and Giri, A. K. (2008). Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes. Environ. Health Perspect. 116, 501-505.
60. Delnomdedieu, M., Basti, M. M., Styblo, M., Otvos, J. D., and Thomas, D. J. (1994). Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7, 621-627.
61. Del Razo, L. M., Quintanilla-Vega, B., Brambila-Colombres, E., Calderon-Avande, E. S., Manno, M., and Albores, A. (2001). Stress proteins induced by arsenic. Toxicol. Appl. Pharmacol. 177, 132-148.
62. Ding, W., Liu, W., Cooper, K. L., Qin, X. J., de Souza Bergo, P. L., Hudson, L. G., and Liu, K. J. (2009). Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem. 384, 6809-6817.
63. Diwan, B. A., Kasprzak, K. S., and Rice, J. M. (1992). Transplacental carcinogenic effects of nickel (II) acetate in the renal cortex, renal pelvis and adenohypophysis in F344/NCr rats. Carcinogenesis 13, 1351-1357.
64. Dixon, H. B. F. (1997). The biochemical action of arsenic acids especially as phosphate analogues. Adv. Inorg. Chem. 44, 191-227.
65. Dong, J.-T., and Lou, X.-M. (1993). Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat. Res. 302, 97-102.
66. Doudoroff, M., Barker, H. A., and Hassid, W. Z. (1947). Studies with bacterial sucrose phosphorylase. III. Arsenolytic decomposition of sucrose and of glucose-1-phosphate. J. Biol. Chem. 170, 147-150.
67. Drobna, Z., Naranmandura, H., Kubachka, K. M., Edwards, B. C., Herbin-Davis, K., Styblo, M., Le, X. C., Creed, J. T., Maeda, N., Hughes, M. F., et al. (2009). Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate. Chem. Res. Toxicol. 22, 1713-1720.
68. Drobna, Z., Waters, S. B., Devesa, V., Harmon, A. W., Thomas, D. J., and Styblo, M. (2005). Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 207, 147-159.
69. Drobna, Z., Waters, S. B., Walton, F. S., LeCluyse, E. L., Thomas, D. J., and Styblo, M. (2004). Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol. Appl. Pharmacol. 201, 166-177.
70. Drobna, Z., Xing, W., Thomas, D. J., and Styblo, M. (2006). shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem. Res. Toxicol. 19, 894-898.
71. Druwe, I. L., and Vaillancourt, R. R. (2010). Influence of arsenate and arsenite on signal transduction pathways: an update. Arch. Toxicol. 84, 585-596.
72. Dunlap, L. G. (1921). Perforations of the nasal septum due to inhalation of arsenous oxide. JAMA 76, 568-569.
73. El-Masri, H. A., and Kenyon, E. M. (2008). Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites. J. Pharmacokinet. Pharmacodyn. 35, 31-68.
74. Endo, G., Kuroda, K., Okamoto, A., and Hiriguchi, S. (1992). Dimethylarsenic acid induces tetraploids in Chinese hamster cells. Bull. Environ. Contam. Toxicol. 48, 131-137.
75. Enterline, P. E., Day, R., and Marsh, G. M. (1995). Cancers related to exposure to arsenic at a copper smelter. Occup. Environ. Med. 52, 28-32.
76. European Commission. (2000). Ambient Air Pollution by AS, CD and NI compounds (Position Paper-Final) Available at: http://ec.europa.eu/environment/air/pdf/pp_as_cd_ni.pdf, pp. 318. Accessed on March 22, 2011.
77. European Food Safety Authority (EFSA). (2009). Scientific opinion on arsenic in food. EFSA J. 7, 1351.
78. Evans, M. V., Dowd, S. M., Kenyon, E. M., Hughes, M. F., and El-Masri, H. A. (2008). A physiologically based pharmacokinetic model for intravenous and ingested dimethylarsinic acid in mice. Toxicol. Sci. 104, 250-260.
79. Feldman, R. G., Niles, C. A., Kelly-Hayes, M., Sax, D. S., Dixon, W. J., Thompson, D. J., and Laundau, E. (1979). Peripheral neuropathy in arsenic smelter workers. Neurology. 29, 939-944.
80. Felix, K., Manna, S. K., Wise, K., Barr, J., and Ramesh, G. T. (2005). Low levels of arsenic activates nuclear factor kappaβ and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 19, 67-77.
81. Ferreccio, C., Gonzalez, C., Milosavjlevic, V., Marshall, G., Sancha, A. M., and Smith, A. H. (2000). Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11, 673-679.
82. Focazio, M. J., Welch, A. H., Watkins, S. A., Helsel, D. R., and Horn, M. A. (1999). A Retrospective Analysis on the Occurrence of Arsenic in Ground-Water Resources of the United States and Limitations in Drinking Water Supply Characterizations. USGS Water-Resources Investigations Report 99-4279, pp.27. Available at: http://pubs.usgs.gov/wri/wri994279/pdf/wri994279.pdf. Accessed on March 23, 2011.
83. Fomenko, D. E., Xing, W., Adair, B. M., Thomas, D. J., and Gladyshev, V. N. (2007). High-throughput identification of catalytic redox-active cysteine residues. Science 315, 387-389.
84. Frisbie, W. S. (1936). Federal control of spray residues on fruits and vegetables. Am. J. Public Health 26, 369-373.
85. Frost, D. V. (1967). Arsenicals in biology-retrospect and prospect. Fed. Proc. 26, 194-207.
86. Fujihara, J., Kunito, T., Agusa, T., Yasuda, T., Iida, R., Fujii, Y., and Takeshita, H. (2007). Population differences in the human arsenic (+3 oxidation state) methyltransferase (AS3MT) gene polymorphism detected by using genotyping method. Toxicol. Appl. Pharmacol. 225, 251-254.
87. Gamble, M. V., Liu, X., Ahsan, H., Pilsner, J. R., Ilievski, V., Slavkovich, V., Parvez, F., Chen, Y., Levy, P., Factor-Litvak, P., et al. (2006). Folate and arsenic metabolism: a double-blind, placebo-controlled folic acidsupplementation trial in Bangladesh. Am. J. Clin. Nutr. 84, 1093-1101.
88. Gentry, P. R., Covington, T. R., Mann, S., Shipp, A. M., Yager, J. W., and Clewell, H. J., 3rd. (2004). Physiologically based pharmacokinetic modeling of arsenic in the mouse. J. Toxicol. Environ. Health A 67, 43-71.
89. Gentry, P. R., McDonald, T. B., Sullivan, D. E., Shipp, A. M., Yager, J. W., and Clewell, H. J., III. (2010). Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ. Molec. Mutagen. 51, 1-14.
90. Germolec, D. R., Spalding, J., Boorman, G. A., Wilmer, J. L., Yoshida, T., Simeonova, P. P., Bruccoleri, A., Kayama, F., Gaido, K., Tennant, R., et al. (1997). Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386, 209-218.
91. Germolec, D. R., Spalding, J., Yu, H.-S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., et al. (1998). Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153, 1775-1785.
92. Germolec, D. R., Yoshida, T., Gaido, K., Wilmer, J. L., Simeonova, P. P., Kayama, F., Burleson, F., Dong, W., Lange, R. W., and Luster, M. I. (1996). Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141, 308-318.
93. Gomez-Rubio, P., Meza-Montenegro, M. M., Cantu-Soto, E., and Klimecki, W. T. (2010). Genetic association between intronic variants in AS3MT and arsenic methylation efficiency is focused on a large linkage disequilibrium cluster in chromosome 10. J. Appl. Toxicol. 30, 260-270.
94. Gong, Z., Lu, X., Cullen, W. R., and Le, X. C. (2001). Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal. At. Spectrom. 16, 1409-1413.
95. Gregus, Z., Roos, G., Geerlings, P., and Németi, B. (2009). Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols. Toxicol. Sci. 110, 282-292.
96. Gresser, M. J. (1981). ADP-arsenate. J. Biol. Chem. 256, 5981-5983.
97. Hall, M., Chen, Y., Ahsan, H., Slavkovich, J., van Geen, A., Parvez, F., and Graziano, J. (2006). Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. Toxicology. 225, 225-233.
98. Haque, R., Mazumder, D. N., Samanta, S., Ghosh, N., Kalman, D., Smith, M. M., Mitra, S., Santra, A., Lahiva, S., Das, S., et al. (2003). Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 14, 174-182.
99. Harden, A. (1932). Alcoholic Fermentation. Monographs on Biochemistry, pp. 243. Longmans, Green & Co, London, U.K.
100. Hartwig, A., Blessing, H., Schwerdtle, T., and Walter, I. (2003). Modulation of DNA repair process by arsenic and selenium compounds. Toxicology 193, 161-169.
101. Hayashi, H., Kanisawa, M., Yamanaka, K., Ito, T., Udaka, N., Ohji, H., Okudela, K., Okada, S., and Kitamura, H. (1998). Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. Cancer Lett. 125, 83-88.
102. Heck, J. E., Andrew, A. S., Onega, T., Rigas, J. R., Jackson, B. P., Karagas, M. R., and Duell, E. J. (2009). Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect. 117, 1718-1723.
103. Hei, T. K., Liu, S. X., and Waldren, C. (1998). Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 95, 8103-8107.
104. Hernandez, A., Xamena, N., Sekaran, C., Tokunaga, H., Sampayo-Reyes, A., Quinteros, D., Creus, A., and Marcos, R. (2008). High arsenic metabolic efficiency in AS3MT287Thr allele carriers. Pharmacogenet. Genomics. 18, 349-355.
105. Hernandez, A., Xamena, N., Surrallés, J., Sekaran, C., Tokunaga, H., Quinteros, D., Creus, A., and Marcos, R. (2007). Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutat. Res. 637, 80-92.
106. Heuper, W. C., and Payne, W. W. (1962). Experimental studies in metal carcinogenesis. Arch. Environ. Health 5, 445-462.
107. Hood, E. (2006). The apple bites back: claiming old orchards for residential development. Environ. Health Perspect. 114, A470-A476.
108. Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicolli, H., and Smith, A. H. (1996). Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 7, 117-124.
109. Hopenhayn-Rich, C., Biggs, M. L., and Smith, A. H. (1998). Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27, 561-569.
110. Hu, Y., Jin, X., and Snow, E. T. (2002). Effect of arsenic on transcription factor AP-1 and NF-kappaβ DNA binding activity and related gene expression. Toxicol. Lett. 133, 33-45.
111. Hu, Y., Su, L., and Snow, E. T. (1998). Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat. Res. 408, 203-218.
112. Huang, C., Ke, Q., Costa, M., and Shi, X. (2004). Molecular mechanisms of arsenic carcinogenesis. Mol. Cell. Biochem. 25, 57-66.
113. Hughes, M. F., Edwards, B. C., Herbin-Davis, K. M., Saunders, J., Styblo, M., and Thomas, D. J. (2010). Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice. Toxicol. Appl. Pharmacol. 249, 217-223.
114. Hughes, M. F., and Kitchin, K. T. (2006). Arsenic, oxidative stress and carcinogenesis. In Oxidative Stress, Disease and Cancer (K. K. Singh, Ed.), pp. 825-850. Imperial College Press, London, U.K.
115. Hyson, J. M., Jr.. (2007). A history of arsenic in dentistry. J. Calif. Dent. Assoc. 35, 135-139.
116. IARC. (2004). Some Drinking-Water Disinfectants and Contaminants, Including Arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, WHO, Lyon, France.
117. Ishinishi, N., Kodama, Y., Nobotomo, K., and Hisanaga, A. (1977). Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung. Environ. Health Perspect. 19, 191-196.
118. Ishinishi, N., Yamamoto, A., Hisanaga, A., and Inamasu, T. (1983). Tumorigenicity of arsenic trioxide to the lung in Syrian Golden hamsters by intermittent instillations. Cancer Lett. 21, 141-147.
119. Jarup, L., Pershagen, G., and Wall, S. (1989). Cumulative arsenic exposure and lung cancer in smelter workers: a dose-response study. Am. J. Ind. Med. 15, 31-41.
120. Jiang, T., Huang, Z., Chan, J. Y., and Zhang, D. D. (2009). Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Toxicol. Appl. Pharmacol. 250, 8-14.
121. Johnston, D., Oppermann, H., Jackson, J., and Levinson, W. (1980). Induction of four proteins in chick embryo cells by sodium arsenite. J. Biol. Chem. 25, 6975-6980.
122. Jolliffe, D. M. (1993). A history of the use of arsenicals in man. J. R. Soc. Med. 86, 287-289.
123. Kaise, T., Oya-Ohta, Y., Ochi, T., Okubo, T., Hanaoka, K., Irgolic, K. J., Sakurai, T., and Matsubara, C. (1996). Toxicological study of organic arsenic compound in marine algae using mammalian cell culture technique. J. Food Hyg. Soc. Jpn. 37, 135-141.
124. Kanisawa, M., and Schroeder, H. A. (1969). Life term studies on the effect of trace elements on spontaneous tumors in mice and rats. Cancer Res. 29, 892-895.
125. Karagas, M. R., Stokel, T. A., Morris, J. S., Tosteson, T. D., Weiss, J. E., Spencer, S. K., and Greenberg, E. R. (2001). Skin cancer risk in relation to toenail arsenic concentrations in a US population based case-control study. Am. J. Epidemiol. 153, 559-565.
126. Karagas, M. R., Tosteson, T. D., Morris, J. S., Demidenko, E., Mott, L. A., Heaney, J., and Schned, A. (2004). Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15, 465-472.
127. Kenyon, E. M., Hughes, M. F., and Levander, O. A. (1997). Influence of dietary selenium on the disposition of arsenate in the female B6C3F1 mouse. J. Toxicol. Environ. Health 51, 279-299.
128. Keyse, S. M., and Tyrrell, R. M. (1989). Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. U. S. A. 86, 99-103.
129. Kitchin, K. T. (2001). Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
130. Kitchin, K. T., and Ahmad, S. (2003). Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol. Lett. 137, 3-13.
131. Kitchin, K. T., and Conolly, R. (2010). Arsenic-induced carcinogenesis- oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment. Chem. Res. Toxicol. 23, 327-335.
132. Kitchin, K. T., and Wallace, K. (2008). Evidence against the nuclear in situ binding of arsenicals-oxidative stress theory of arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 232, 252-257.
133. Kligerman, A. D., Doerr, C. L., Tennant, A. H., Harrington-Brock, K., Allen, J. W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B. C., et al. (2003). Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen. 42, 192-205.
134. Kubachka, K. M., Kohan, M. J., Herbin-Davis, K., Creed, J. T., and Thomas, D. J. (2009). Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS. Toxicol. Appl. Pharmacol. 239, 137-143.
135. Kumagi, Y., and Sumi, D. (2007). Arsenic: signal transduction, transcription factor and biotransformation involved in cellular response and toxicity. Annu. Rev. Pharmacol. Toxicol. 47, 243-262.
136. Lagerkvist, B., Linderholm, H., and Nordberg, G. F. (1986). Vasospastic tendency and Raynaud's phenomenon in smelter workers exposed to arsenic. Environ. Res. 39, 465-474.
137. Landner, L. (1972). The biological alkylation of mercury. Biochem. J. 130, 67P-69P.
138. Lantz, R. C., and Hays, A. M. (2006). Role of oxidative stress in arsenicinduced toxicity. Drug Metab. Rev. 38, 791-804.
139. Lee, A. M., and Franmeni, J. F. (1969). Arsenic and respiratory cancer in man. An occupational study. J. Natl. Cancer Inst. 42, 1045-1052.
140. Lee, T.-C., Wang-Wuu, S., Huang, R. Y., Lee, K. C. C., and Jan, K. Y. (1986). Differential effects of pre- and posttreatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chinese hamster ovary cells. Cancer Res. 46, 1854-1857.
141. Leitch, A. L. (1923). The experimental inquiry into the causes of cancer. Br. Med. J. 2, 1-7.
142. Leitch, A. L., and Kennaway, E. L. (1922). Experimental production of cancer by arsenic. Br. Med. J. 2, 1107-1108.
143. Leonard, S. S., Harris, G. K., and Shi, X. (2004). Metal-induced oxidative stress and signal transduction. Free Radic. Biol. Med. 37, 1921-1942.
144. Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J., and Calderon, R. L. (1999). Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 107, 359-365.
145. Li, J.-H., and Rossman, T. G. (1989a). Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol. Trace Element Res. 28, 373-381.
146. Li, J.-H., and Rossman, T. G. (1989b). Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2, 1-9.
147. Li, J.-H., and Rossman, T. G. (1991). Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol. Metals 4, 197-200.
148. Liao, C. M., Lin, T. L., and Chen, S. C. (2008). A Weibull-PBPK model for assessing risk of arsenic-induced skin lesions in children. Sci. Total Environ. 392, 203-217.
149. Lin, G. F., Du, H., Chen, J. G., Lu, H. C., Kai, J. X., Zhou, Y. S., Guo, W. C., Zhang, X. J., Lu, D. R., Golka, K., et al. (2007). Glutathione S-transferases M1 and T1 polymorphisms and arsenic content in hair and urine in two ethnic clans exposed to indoor combustion of high arsenic coal in Southwest Guizhou, China. Arch. Toxicol. 81, 545-551.
150. Lin, S., Del Razo, L. M., Styblo, M., Wang, C., Cullen, W. R., and Thomas, D. J. (2001). Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem. Res. Toxicol. 14, 305-311.
151. Lin, S., Shi, Q., Nix, F. B., Styblo, M., Beck, M. A., Herbin-Davis, K. M., Hall, L. L., Simeonsson, J. B., and Thomas, D. J. (2002). A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J. Biol. Chem. 277, 10795-10803.
152. Lindberg, A. L., Kumar, R., Goessler, W., Thirumaran, R., Gurzau, E., Koppova, K., Rudnai, P., Leonardi, G., Fletcher, T., and Vahter, M. (2007). Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ. Health Perspect. 115, 1081-1086.
153. Lindgren, A., Danielsson, R. G., Dencker, W., and Vahter, M. (1984). Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol. Toxicol. 54, 311-320.
154. Liu, S. X., Athar, M., Lippai, I., Waldren, C., and Hei, T. K. (2001). Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U. S. A. 98, 1643-1648.
155. Liu, Y., Guyton, K. Z., Gorospe, M., Xu, Q., Lee, J. C., and Holbrook, N. J. (1996). Differential activation of ERK, JNK/SAPK and p38/CSBP/RK MAP kinase family members during the cellular response to arsenite. Free Radic. Biol. Med. 21, 771-781.
156. Lloyd, N. C., Morgan, H. W., Nicholson, B. K., and Ronimus, R. S. (2005). The composition of Ehrlich's Salvarsan: resolution of a century-old debate. Angew. Chem. Int. Ed. 44, 941-944.
157. Lu, M., Wang, H., Li, X.-F., Arnold, L. L., Cohen, S. M., and Le, X. C. (2007). Binding of dimethylarsinous acid to Cys-13α of rat hemoglobin is responsible for the retention of arsenic in rat blood. Chem. Res. Toxicol. 20, 27-37.
158. Luster, M. I., and Simeonova, P. P. (2004). Arsenic and urinary bladder cell proliferation. Toxicol. Appl. Pharmacol. 198, 419-423.
159. Lynn, S., Gurr, J. R., Lai, H. T., and Jan, K. Y. (2000). NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 85, 514-519.
160. Mabuchi, K., Lilienfeld, A. M., and Snell, L. M. (1980). Cancer and occupational exposure to arsenic: a study of pesticide workers. Prev. Med. 9, 51-77.
161. Maine Rural Health. (2008). Maine Rural Health Association 2003 Outstanding Service Award Available at: http://www.maineruralhealth.org/award.htm. Accessed December 3, 2010.
162. Mann, S., Droz, P. O., and Vahter, M. (1996a). A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits. Toxicol. Appl. Pharmacol. 137, 8-22.
163. Mann, S., Droz, P. O., and Vahter, M. (1996b). A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans. Toxicol. Appl. Pharmacol. 140, 471-486.
164. Marafante, E., Vahter, M., Norin, H., Envall, J., Sandström, M., Christakopoulos, A., and Ryhage, R. (1987). Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7, 111-117.
165. Marsh, G. M., Stone, R. A., Esmen, N. A., Gula, M. J., Gause, C. K., Petersen, N. J., Meaney, F. J., Rodney, S., and Prybylski, D. (1997). A case-control study of lung cancer mortality in six Gila basin, Arizona smelter towns. Environ. Res. 75, 56-72.
166. Marsh, J. (1837). Separation of arsenic. In The American Journal of Pharmacy (J. Carson, Ed.), Vol. II, pp. 307-314. Merriew and Gunn, Philadelphia, PA.
167. Marshall, G., Ferreccio, C., Yuan, Y., Bates, M. N., Steinmaus, C., Selvin, S., Liaw, J., and Smith, A. H. (2007). Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer Inst. 99, 920-928.
168. Mass, M. J., Tennant, A., Roop, B. C., Cullen, W. R., Styblo, M., Thomas, D. J., and Kligerman, A. D. (2001). Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14, 355-361.
169. Mass, M. J., and Wang, L. (1997). Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386, 263-277.
170. Mazumder, D. N., Haque, R., Ghosh, N., De, B. K., Chakraborti, D., and Smith, A. H. (2000). Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int. J. Epidemiol. 29, 1047-1052.
171. McCarty, K. M., Chen, Y. C., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., Hsueh, Y. M., Su, L., Smith, T., Ryan, L., and Christiani, D. C. (2007a). Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ. Health Perspect. 115, 341-345.
172. McCarty, K. M., Houseman, E. A., Quamruzzaman, Q., Rahman, M., Mahsuddin, G., Smith, T., Ryan, L., and Christiani, D. C. (2006). The impact of diet and betel nut use on skin lesions associated with drinkingwater arsenic in Pabna, Bangladesh. Environ. Health Perspect. 114, 334-340.
173. McCarty, K. M., Ryan, L., Houseman, E. A., Williams, P. L., Miller, D. P., Quamruzzaman, Q., Rahman, M., Mahiuddin, G., Smith, T., Gonzalez, E., et al. (2007b). A case-control study of GST polymorphisms and arsenic related skin lesions. Environ. Health 6, 5.
174. Meza, M. M., Yu, L., Rodriguez, Y. Y., Guild, M., Thompson, D., Gandolfi, A. J., and Klimecki, W. T. (2005). Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. Environ. Health Perspect. 113, 775-781.
175. Mozier, N. M., McConnell, K. P., and Hoffman, J. L. (1988). S-adenosyl-Lmethionine: thioether S-methyltransferase, a new enzyme in sulfur and selenium metabolism. J. Biol. Chem. 263, 4527-4531.
176. Mumford, J. L., Wu, K., Xia, Y., Kwok, R., Yang, Z., Foster, J., and Sanders, W. E. (2007). Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 115, 690-694.
177. Murgo, A. J. (2001). Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist 6, 22-28.
178. Navas-Acien, A., Silbergeld, E. K., Pastor-Barriuso, R., and Guallar, E. (2008). Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 300, 814-822.
179. Nelson, W. C., Lykins, M. H., Mackey, J., Newill, V. A., Finklea, J. F., and Hammer, D. I. (1973). Mortality among orchard workers exposed to lead arsenate spray: a cohort study. J. Chronic Dis. 26, 105-118.
180. Nemeti, B., Regonesi, M. E., Tortora, P., and Gregus, Z. (2010). Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP. Toxicol. Sci. 117, 270-281.
181. Nesnow, S., Roop, B. C., Lambert, G., Kadiiska, M., Mason, R. P., Cullen, W. R., and Mass, M. J. (2002). DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 14, 1627-1634.
182. Neubauer, O. (1947). Arsenical cancer: a review. Br. J. Cancer 1, 192-251.
183. Newton, D. E. (2007). In Forensic Chemistry. Infobase Publishing, New York, NY.
184. Nishioka, H. (1975). Mutagenic activities of metal compounds in bacteria. Mutat. Res. 31, 185-189.
185. Nordstrom, D. K. (2002). Worldwide occurrences of arsenic in ground water. Science 296, 2143-2145.
186. NRC. (1999). Arsenic in Drinking Water. National Research Council, National Academy Press, Washington, DC.
187. NRC. (2001). Arsenic in Drinking Water. Update to the 1999 Arsenic in Drinking Water Report. National Research Council, National Academy Press, Washington, DC.
188. Ott, M. G., Holder, B. B., and Gordon, H. L. (1974). Respiratory cancer and occupational exposure to arsenicals. Arch. Environ. Health 29, 250-255.
189. Paiva, L., Hernández, A., Martínez, V., Creus, A., Quinteros, D., and Marcos, R. (2010). Association between GSTO2 polymorphism and the urinary arsenic profile in copper industry workers. Environ. Res. 110, 463-468.
190. Parascandola, J. (1977). Carl Voegtlin and the 'arsenic receptor' in chemotherapy. J. Hist. Med. Allied Sci. 23, 151-171.
191. Parvez, F., Chen, Y., Brandt-Rauf, P. W., Slavkovich, V., Islam, T., Ahmed, A., Argos, M., Hassan, R., Yunus, M., Haque, S. E., et al. (2010). A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the Health Effects of Arsenic Longitudinal Study (HEALS). Thorax. 65, 528-533.
192. Pershagen, G., and Bjorklund, N.-E. (1985). On the pulmonary tumorigenicity of arsenic trisulfide and calcium arsenate in hamsters. Cancer Lett. 27, 99-104.
193. Pershagen, G., Nordberg, G., and Bjorklund, N.-E. (1984). Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo(a)pyrene by the pulmonary route. Environ. Res. 34, 227-241.
194. Peryea, F. J. (1998). Historical use of lead arsenate insecticides, resulting soil contamination and implications for soil remediation. In Proceedings, 16th World Congress of Soil Science, 20-26 August 1998, Montpelllier, France, pp. 7. Available at: http://soils.tfrec.wsu.edu/leadhistory.htm.
195. Peters, R. A. (1949). The study of enzymes in relation to selective toxicity in animal tissues. Symp. Soc. Exper. Biol. 3, 36-59.
196. Peters, R. A., Stocken, L. A., and Thompson, R. H. S. (1945). British antilewisite. Nature. 156, 616-619.
197. Petito Boyce, C., Lewis, A. S., Sax, S. N., Eldan, M., Cohen, S. M., and Beck, B. D. (2008). Probabilistic analysis of human health risks associated with background concentrations of inorganic arsenic: use of a margin exposure approach. Hum. Ecol. Risk Assess. 14, 1159-1201.
198. Piatek, K., Schwerdtle, T., Hartwig, A., and Bal, W. (2008). Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition. Chem. Res. Toxicol. 21, 600-606.
199. Pilsner, J. R., Hall, M. N., Liu, X., Ahsan, H., Ilievski, V., Slavkovich, V., Levy, D., Factor-Litvak, P., Graziano, J. H., and Gamble, M. V. (2007). Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ. Health Perspect. 117, 254-260.
200. Pilsner, J. R., Hall, M. N., Liu, X., Ahsan, H., Ilievski, V., Slavkovich, V., Levy, D., Factor-Litvak, P., Graziano, J. H., and Gamble, M. V. (2011). Associations of plasma selenium with arsenic and genomic methylation of leukocyte DNA in Bangladesh. Environ. Health Perspect. 119, 113-118.
201. Pilsner, J. R., Liu, X., Ahsan, H., Ilievski, V., Slavkovich, V., Levy, D., Factor-Litvak, P., Graziano, J. H., and Gamble, M. V. (2007). Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am. J. Clin. Nutr. 86, 1179-1186.
202. Pilsner, J. R., Liu, X., Ahsan, H., Ilievski, V., Slavkovich, V., Levy, D., Factor-Litvak, P., Graziano, J. H., and Gamble, M. V. (2009). Folate deficiency, hyperhomocysteinemia, low urinary creatinine and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ. Health Perspect. 117, 254-260.
203. Pinto, S. S., Enterline, P. E., Henderson, V., and Varner, M. O. (1977). Mortality experience in relation to a measured arsenic trioxide exposure. Environ. Health Perspect. 19, 127-130.
204. Pinyayev, T. S., Kohan, M. J., Herbin-Davis, K., Creed, J. T., and Thomas, D. J. (2011). Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem. Res. Toxicol. 24, 475-477.
205. Platanias, L. C. (2009). Biological responses to arsenic compounds. J. Biol. Chem. 284, 18583-18587.
206. Porter, K. E., Basu, A., Hubbard, A. E., Bates, M. N., Kalman, D., Rey, O., Smith, A., Smith, M. T., Steinmaus, C., and Skibola, C. F. (2010). Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism. Environ. Res. 110, 580-587.
207. Rahman, A., Vahter, M., Ekstrom, E. C., Rahman, M., Golan Mustafa, A. H., Waheed, M. A., Yunus, M., and Persson, L. A. (2007). Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am. J. Epidemiol. 165, 1389-1396.
208. Rahman, A., Vahter, M., Smith, A. H., Nermell, B., Yunus, M., El Arifeen, S., Persson, L. A., and Ekstrom, E. C. (2009). Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am. J. Epidemiol. 169, 304-312.
209. Rahman, M., Tondel, M., Ahmad, S. A., Chowdhury, I. A., Faruquee, M. H., and Axelson, O. (1999). Hypertension and arsenic exposure in Bangladesh. Hypertension 33, 74-78.
210. Riethmiller, S. (2005). From Atoxyl to Salvarsan: searching for the magic bullet. Chemotherapy 51, 235-242.
211. Roberts, S. M., Weimar, W. R., Vinson, J. R. T., Munson, J. W., and Bergeron, R. J. (2002). Measurement of arsenic bioavailability in soil using a primate model. Toxicol. Sci. 67, 303-310.
212. Rohe, G. H. (1896). Arsenic. In Reference-Book of Practical Therapeutics, (F. P. Foster, Ed.), Vol.1, pp. 142-146. D. Appleton and Company, New York. Available at: http://www.archive.org/details/cu31924104225978. Accessed July 27, 2011.
213. Rosenthal, S. M. (1932). Action of arsenic upon the fixed sulphydryl groups of proteins. Public Health Rep. 47, 241-256.
214. Rossman, T. G. (1981). Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli. Mutat. Res. 91, 207-211.
215. Rossman, T. G. (2003). Mechanisms of arsenic carcinogenesis. An integrated approach. Mutat. Res. 533, 37-65.
216. Rossman, T. G., Meyn, M. S., and Troll, W. (1977). Effects of arsenite on DNA repair in Escherichia coli. Environ. Health Perspect. 19, 229-233.
217. Rossman, T. G., Uddin, A. N., Burns, F. S., and Bosland, M. C. (2001). Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin. An animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176, 64-71.
218. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llaamazares, A., Zamanillo, D., Hunt, T., and Nebreda, A. R. (1994). A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78, 1027-1037.
219. Roussel, R. R., and Barchowsky, A. (2000). Arsenic inhibits NF-kappaβmediated gene transcription by blocking Ikappaβ phosphorylation and degradation. Arch. Biochem. Biophys. 377, 204-212.
220. Rust, D. M., and Soignet, S. L. (2001). Risk/benefit profile of arsenic trioxide. Oncologist. 6(Suppl. 2), 29-32.
221. Samikkannu, T., Chen, C. H., Yih, L. H., Wang, A. S., Lin, S. Y., Chen, T. C., and Jan, K. Y. (2003). Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 16, 409-414.
222. Sampayo-Reyes, A., Hernandez, A., El-Yamani, N., Lopez-Campos, C., Mayet-Machado, E., Rincon-Castaneda, C. B., Limones-Aguilar Mde, L., Lopez-Campos, J. E., de Leon, M. B., González-Hernández, S., et al. (2010). Arsenic induces DNA damage in environmentally exposed Mexican children and adults. Influence of GSTO1 and AS3MT polymorphisms. Toxicol. Sci. 117, 63-71.
223. Saxe, J. K., Bowers, T. S., and Reid, K. R. (2006). Arsenic. In Environmental Forensics: Contaminant Specific Guide (R. D. Morrison and B. L. Murphy, Eds.), pp. 279-292. Academic Press, Burlington, MA.
224. Scheindlin, S. (2005). The duplicitous nature of inorganic arsenic. Mol. Interv. 5, 60-64.
225. Schläwicke Engström, K., Broberg, K., Concha, G., Nermell, B., Warholm, M., and Vahter, M. (2007). Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ. Health Perspect. 115, 599-605.
226. Schmeisser, E., Goessler, W., and Francesconi, K. A. (2006). Human metabolism of arsenolipids present in cod liver. Anal. Bioanal. Chem. 385, 367-376.
227. Schoen, A., Beck, B., Jharma, R., and Dube, E. (2004). Arsenic toxicity of low doses: epidemiology and mode of action consideration. Toxicol. Appl. Pharmacol. 198, 253-267.
228. Schoof, R. A., Eickhoff, J., Yost, L. J., Crecelius, E. A., Cragin, D. W., Meacher, D. M., and Menzel, D. B. (1999). Dietary exposure to inorganic arsenic. In Arsenic Exposure and Health Effects (W. R. Chappell, C. O. Abernathy, and R. L. Calderon, Eds.), pp. 81-88. Elsevier Science B.V., Amsterdam, The Netherlands.
229. Schroeder, H. A., Kanisawa, M., Frost, D. V., and Mitchener, M. (1968). Germanium, tin and arsenic in rats: effects on growth, survival, pathological lesions and life span. J. Nutrition 96, 37-45.
230. Schumacher-Wolz, U., Dieter, H. H., Klein, D., and Schneider, K. (2009). Oral exposure to inorganic arsenic: evaluation of its carcinogenic and noncarcinogenic effects. Crit. Rev. Toxicol. 39, 271-298.
231. Schumilla, J. A., Wetterhahn, K. E., and Barchowsky, A. (1998). Inhibition of NF-kappa b binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch. Biochem. Biophys. 349, 356-362.
232. Sekeres, M. S. (2007). New data with arsenic trioxide in leukemias and myelodysplastic syndromes. Clin. Lymphoma Myeloma 8(Suppl. 1), S7-S12.
233. Shacklette, H. T., and Boerngen, J. G. (1984). Element Concentrations in Soils and Other Surficial Materials of the Conterminous United States U.S. Government Printing Office US Geological Survey Professional Paper 1270, pp. 15. U.S. Government Printing Office, Washington, DC. Available at: http://pubs.usgs.gov/pp/pdf/1270/PP1270_508.pdf. Accessed July 27, 2011.
234. Shi, H., Shi, X., and Liu, K. J. (2004). Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell. Biochem. 255, 67-78.
235. Simeonova, P. P., Wang, S., Hulderman, T., and Luster, M. I. (2002). c-Srcdependent activation of the epidermal growth factor receptor and mitogenactivated protein kinase pathway by arsenic. J. Biol. Chem. 277, 2945-2950.
236. Simeonova, P. P., Wang, S., Toriuma, W., Kommineni, V., Matheson, J., Unimye, N., Kayama, F., Harki, D., Ding, M., Vallyathan, V., et al. (2000). Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 60, 2445-3453.
237. Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998). Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147, 660-669.
238. Smith, K. R., Klei, L. R., and Barchowsky, A. (2001). Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L442-L449.
239. Smith, A. H., Lingas, E. O., and Rahman, M. (2000). Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull. World Health Organ. 78, 1093-1103.
240. Smith, A. H., Marshall, G., Yuan, Y., Ferreccio, C., Liaw, J., von Ehrenstein, O., Steinmaus, C., Bates, M. N., and Selvin, S. (2006). Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114, 1293-1296.
241. Smith, A. H., and Steinmaus, C. M. (2009). Health effects of arsenic and chromium in drinking water: recent human findings. Annu. Rev. Public Health. 30, 107-122.
242. Sohel, N., Persson, L. A., Rahman, M., Streatfield, P. K., Yunus, M., Ekström, E. C., and Vahter, M. (2009). Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology. 20, 824-830.
243. Spor, A., Koren, O., and Ley, R. (2011). Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9, 279-290.
244. Steinmaus, C., Moore, L. E., Shipp, M., Kalman, D., Rey, O. A., Biggs, M. L., Hopenhayn, C., Bates, M. N., Zheng, S., Wiencke, J. K., et al. (2007). Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J. Toxicol. Environ. Health A. 70, 159-170.
245. Steinmaus, C., Yuan, Y., Bates, M. N., and Smith, A. H. (2003). Case-control study of bladder cancer and drinking water arsenic in the western United States. Am. J. Epidemiol. 158, 1193-2001.
246. Stocken, L. A., and Thompson, R. H. S. (1946). British anti-lewisite. 1. Arsenic derivatives of thiol proteins. Biochem. J. 40, 529-535.
247. Straub, A. C., Clark, K. A., Ross, M. A., Chandra, A. G., Li, S., Gao, X., Pagano, P. J., Stolz, D. B., and Barchowsky, A. (2008). Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J. Clin. Invest. 118, 3980-3989.
248. Styblo, M., Serves, S. V., Cullen, W. R., and Thomas, D. J. (1997). Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10, 27-33.
249. Suzuki, S., Arnold, L. L., Pennington, K. L., Chen, B., Naranmandura, H., Le, X. C., and Cohen, S. M. (2010). Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium. Toxicol. Appl. Pharmacol. 244, 99-105.
250. Sykora, P., and Snow, E. T. (2008). Modulation of DNA polymerase betadependent base excision repair in cultured human cells after low dose exposure to arsenite. Toxicol. Appl. Pharmacol. 228, 385-394.
251. Tapio, S., and Grosche, B. (2006). Arsenic in the aetiology of cancer. Mutat. Res. 612, 215-246.
252. Taylor, A. S. (1873). Metallic Irritants. The Principles and Practice of Medical Jurisprudence (A. S. Taylor Ed.), 2nd ed., Vol. 1., pp. 250-279. J & A Churchill, London, U.K.
253. Thomas, D. J., Li, J., Waters, S. B., Xing, W., Adair, B. M., Drobna, Z., Devesa, V., and Styblo, M. (2007). Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp. Biol. Med. (Maywood). 232, 3-13.
254. Thorgeirsson, U. P., Dalgard, D. W., Reeves, J., and Adamson, R. H. (1994). Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Regul. Toxicol. Pharmacol. 19, 130-151.
255. Tokar, E. J., Diwan, B. A., Ward, J. M., Delker, D. A., and Waalkes, M. P. (2011a). Carcinogenic effects of "whole life" exposure to inorganic arsenic in CD1 mice. Toxicol. Sci. 119, 73-83.
256. Tokar, E. J., Qu, W., and Waalkes, M. P. (2011b). Arsenic, stem cells and the developmental basis of adult cancer. Toxicol. Sci. 120(Suppl. 1), S192-S203.
257. Tollestrup, K., Daling, J. R., and Allard, J. (1995). Mortality in a cohort of orchard workers exposed to lead arsenate pesticide spray. Arch. Environ. Health. 50, 221-229.
258. Tollestrup, K., Frost, F. J., Harter, L. C., and McMillan, G. P. (2003). Mortality among children residing near the American Smelting and Refining Company (ASARCO) copper smelter in Ruston, Washington. Arch. Environ. Health. 58, 683-691.
259. Tseng, C. H., Chong, C. K., Chen, C. J., and Tai, T. Y. (1996). Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis. 120, 125-133.
260. Tseng, W. P., Chu, H. M., How, S. W., Fong, J. M., Lin, C. S., and Yeh, S. (1968). Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40, 453-463.
261. U.S. EPA. (1988). Special Report on Ingested Inorganic Arsenic. Skin Cancer; Nutritional Essentiality, EPA/625/3-87/013. Risk Assessment Forum, Washington DC.
262. U.S. EPA. (2001). Risk Assessment Guidance for Superfund (RAGS) Volume I: Human Health Evaluation Manual (Part E, Supplemental Guidance for Dermal Risk Assessment, Interim) (Draft). EPA/540/R.99/005; OSWER 9284.7-102.EP Available at: http://www.epa.gov/oswer/riskassessment/ragse/index.htm. Accessed November 29, 2010.
263. U.S. EPA. (2006). Revised Reregistration Eligibility Decision for MSMA, DSMA, CAMA and Cacodylic Acid. EPA-738-R-06-021 Available at: http://www.epa.gov/oppsrrd1/REDs/organic_arsenicals_red.pdf. Accessed July 27, 2011.
264. U.S. EPA. (2007). Letter to S. Johnson (U.S. EPA) re: Advisory on EPA's Assessments of Carcinogenic Effects of Organic and Inorganic Arsenic: A report of the U.S. EPA Science Advisory Board. EPA-SAB-07-008 Available at: http://epa.gov/sab/pdf/sab-07-008.pdf.
265. U.S. EPA. (2008). Reregistration Eligibility Decision for Chromated Arsenicals. EPA 739-R-08-1006, p. 90. Available at: http://www.epa.gov/oppsrrd1/REDs/cca_red.pdf. Accessed July 27, 2011.
266. U.S. EPA. (2009). Amendment to Organic Arsenicals RED Available at: http://www.epa.gov/oppsrrd1/REDs/organic-arsenicals-amended.pdf. Accessed on March 31, 2011.
267. Uthus, E. O. (1992). Evidence for arsenic essentiality. Environ. Geochem. Health. 14, 55-58.
268. Uthus, E. O. (2003). Arsenic essentiality. A role affecting methionine essentiality. J. Trace Elem. Exp. Med. 16, 345-355.
269. Vahidnia, A., van der Voet, G. B., and de Wolff, F. A. (2007). Arsenic neurotoxicity-a review. Hum. Exp. Toxicol. 26, 823-832.
270. Vahter, M., and Marafante, E. (1987). Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol. Lett. 37, 41-46.
271. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13, 259-264.
272. Valenzuela, O. L., Drobna, Z., Hernandez-Castellanos, E., Sanchez-Pena, L. C., García-Vargas, G. G., Borja-Aburto, V. H., Styblo, M., and Del Razo, L. M. (2009). Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions. Toxicol. Appl. Pharmacol. 239, 200-207.
273. Vlaanderen, J., Moore, L. E., Smith, M. T., Lan, Q., Zhang, L., Skibola, C. F., Rothman, N., and Vermeulen, R. (2010). Application of OMICS technologies in occupational and environmental health research; current status and projections. Occup. Environ. Med. 67, 136-143.
274. Voegtlin, C. (1925). The pharmacology of arsphenamine (Salvarsan) and related compounds. Physiol. Rev. 5, 563-594.
275. Voegtlin, C., Dyer, H. A., and Leonard, C. S. (1923). On the mechanism of the action of arsenic upon protoplasm. Public Health Rep. 38, 1882-1912.
276. von Ehrenstein, O. S., Guha Mazumder, D. N., Hira-Smith, M., Ghosh, N., Yuan, Y., Windam, G., Gosh, A., Haque, R., Lahir, S., Kalman, D., et al. (2006). Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 163, 662-669.
277. von Ehrenstein, O. S., Mazumder, D. N., Yuan, Y., Samanta, S., Balmes, J., Sil, A., Ghosh, N., Hira-Smith, M., Haque, R., Purushothaman, R., et al. (2005). Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am. J. Epidemiol. 162, 533-541.
278. von Ehrenstein, O. S., Poddar, S., Yuan, Y., Mazumder, D. G., Eskenazi, B., Basu, A., Hira-Smith, M., Gosh, N., Labiri, S., Haque, R., et al. (2007). Children's intellectual function in relation to arsenic exposure. Epidemiology. 18, 44-51.
279. 1 mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy. Cancer Res. 55, 5265-5271.
280. Waalkes, M. P., Liu, J., Germolec, D. R., Trempus, C. S., Cannon, R. E., Tokar, E. J., Tennant, R. W., Ward, J. M., and Diwan, B. A. (2008). Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics. Cancer Res. 68, 8278-8285.
281. Waalkes, M. P., Ward, J. M., and Diwan, B. A. (2004). Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis. 25, 133-141.
282. Waalkes, M. P., Ward, J., Liu, J., and Diwan, B. A. (2003). Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic ovarian, pulmonary and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186, 7-17.
283. Walton, F. S., Waters, S. B., Jolley, S. L., LeCluyse, E. L., Thomas, D. J., and Styblo, M. (2003). Selenium compounds modulate the activity of recombinant rat AsIII-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem. Res. Toxicol. 16, 261-265.
284. Wang, X.-J., Sun, Z., Chen, W., Eblin, K. E., Gandolfi, J. A., and Zhang, D. D. (2007). Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol. Appl. Pharmacol. 225, 206-213.
285. Wang, X.-J., Sun, Z., Chen, W., Li, Y., Villeneuve, N. F., and Zhang, D. D. (2008). Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol. Appl. Pharmacol. 230, 383-389.
286. Wang, Y. H., Yeh, S. D., Shen, K. H., Shen, C. H., Juang, G. D., Hsu, L. I., Chiou, H. Y., and Chen, C. J. (2009). A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. Toxicol. Appl. Pharmacol. 241, 111-118.
287. Wang, Z., and Zhang, J. (2009). Abundant indispensable redundancies in cellular metabolic networks. Genome Biol. Evol. 1, 23-33.
288. Wanibuchi, H., Yamamoto, S., Chen, H., Yoshida, K., Endo, G., Hori, T., and Fukushima, S. (1996). Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis. 17, 2435-2439.
289. Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., Kline, J., van Geen, A., Slavkovich, V., Lolacono, N. J., Levy, D., et al. (2007). Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ. Health Perspect. 115, 285-289.
290. Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Factor-Litvak, P., van Geen, A., Slavkovich, V., Lolacono, N. J., Cheng, Z., Hussain, I., et al. (2004). Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 112, 1329-1333.
291. Waters, S. B., Devesa, V., Del Razo, L. M., Styblo, M., and Thomas, D. J. (2004a). Endogenous reductants support the catalytic function of recombinant rat cyt19, an arsenic methyltransferase. Chem. Res. Toxicol. 17, 404-409.
292. Waters, S. B., Devesa, V., Fricke, M. W., Creed, J. T., Stý blo, M., and Thomas, D. J. (2004b). Glutathione modulates recombinant rat arsenic (+3 oxidation state) methyltransferase-catalyzed formation of trimethylarsine oxide and trimethylarsine. Chem. Res. Toxicol. 17, 1621-1629.
293. Waxman, S., and Anderson, K. C. (2001). History of the development of arsenic derivatives in cancer therapy. Oncologist. 6, 3-10.
294. Wei, M., Cohen, S. M., Cao, M., and Arnold, L. L. (2005). Effects of coadministration of antioxidants and arsenicals on the rat urinary bladder epithelium. Toxicol. Sci. 83, 237-245.
295. Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., and Fukushima, S. (2002). Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 23, 1387-1397.
296. Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., and Fukushima, S. (1999). Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis. 20, 1873-2187.
297. Welch, K., Higgins, I., Oh, M., and Burchfiel, C. (1982). Arsenic exposure, smoking and respiratory cancer in copper smelter workers. Arch. Environ. Health. 37, 325-335.
298. Winski, S. L., and Carter, D. E. (1998). Arsenate toxicity in human erythrocytes: characterization of morphologic changes and determination of the mechanism of damage. J. Toxicol. Environ. Health. 53, 345-355.
299. Wijeweera, J. B., Gandolfi, A. J., Parrish, A., and Lantz, R. C. (2001). Sodium arsenite enhances AP-1 and NFkappaβ and DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol. Sci. 61, 283-294.
300. Wood, E. S. (1885). In: Arsenic as a Domestic Poison. Wright & Potter Printing Co., Boston, MA.
301. Wood, J. M. (1974). Biological cycles for toxic elements in the environment. Science. 183, 1049-1052.
302. Wood, T. C., Salavagionne, O. E., Mukherjee, B., Wang, L., Klumpp, A. F., Thomae, B. A., Eckloff, B. W., Schaid, D. J., Wieben, E. D., and Weinshilboum, R. M. (2006). Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J. Biol. Chem. 281, 7364-7373.
303. WPSC. (2008). The Safety of Chromated Copper Arsenate (CCA)-Treated Wood, pp. 2.Wood Preservative Science Council. Available at: http://www.woodpreservativescience.org/safety.shtml. Accessed December 3, 2010.
304. Wu, F., Burns, F. J., Zhang, R., Uddin, A. N., and Rossman, T. G. (2005). Arsenite-induced alterations of DNA photodamage repair and apoptosis after solar-simulation UVR in mouse keratinocytes in vitro. Environ. Health Perspect. 113, 983-986.
305. Yager, J. W., Hicks, J. B., and Fabianova, E. (1997). Airborne arsenic and urinary excretion of arsenic metabolites during boiler cleaning operations in a Slovak coal-fired power plant. Environ. Health Perspect. 105, 836-842.
306. Yamamoto, A., Hisanaga, A., and Ishinishi, N. (1987). Tumorigenicity of inorganic arsenic compounds following intratracheal instillations to the lungs of hamsters. Int. J. Cancer. 40, 220-223.
307. Yamamoto, S., Konishi, Y., Matsuda, T., Murai, T., Shibata, M.-A., Matsui-Yuasa, I., Otani, S., Kuroda, K., Endo, G., and Fukushima, S. (1995). Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55, 1271-1276.
308. Yamanaka, K., Hasegawa, A., Sawamura, R., and Okada, S. (1989). Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice. Biochem. Biophys. Res. Commun. 165, 43-50.
309. Yamanaka, K., Hoshino, M., Okamoto, M., Sawamura, R., Hasegawa, A., and Okada, S. (1990). Induction of DNA damage by dimethylarsine, a metabolite of arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 168, 58-64.
310. Yamanaka, K., Ohtsubo, K., Hasegawa, A., Hayashi, H., Ohgi, H., Kanisawa, M., and Okada, S. (1996). Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenesis initiated by 4-nitroquinoline 1-oxide in the lungs of mice. Carcinogenesis. 17, 767-770.
311. Yamanaka, K., and Okada, S. (1994). Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ. Health Perspect. 102(Suppl. 3), 37-40.
312. Yan-Chu, H. (1994). Arsenic distribution in soils. In: Arsenic in the Environment, Part I; Cycling and Characterization (J. O. Nriagu, Ed.), pp. 17-47. John Wiley and Sons, Inc., Hoboken, NJ.
313. Yang, C., and Frenkel, K. (2002). Arsenic-mediated cellular signal transduction, transcription factor activation and aberrant gene expression: implications in carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 21, 331-342.
314. Yarnell, A. (2005). Salvarsan. Chem. Eng. News 83, 116.
315. Yokohira, M., Arnold, L. L., Pennington, K. L., Suzuki, S., Kakiuchi-Kiyota, S., Herbin-Davis, K., Thomas, D. J., and Cohen, S. M. (2010). Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia induced by arsenite in arsenic (+3 oxidation state) methyltransferase knockout mice. A preliminary report. Toxicol. Appl. Pharmacol. 246, 1-7.
316. Yorifuji, T., Tsuda, T., and Grandjean, P. (2010). Unusual cancer excess after neonatal arsenic exposure from contaminated milk powder. J. Natl. Cancer Inst. 102, 360-361.
317. Yost, L. J., Tao, S. H., Egan, S. K., Barraj, L. M., Smith, K. M., Tsuji, J. S., Lowney, Y. W., Schoof, R. A., and Rachman, N. J. (2004). Estimation of dietary intake of inorganic arsenic in U.S. children. Hum. Ecol. Risk Assess. 10, 473-483.
318. Yu, D. (1999). A physiologically based pharmacokinetic model of inorganic arsenic. Regul. Toxicol. Pharmacol. 29, 128-141.
319. Yuan, Y., Marshall, G., Ferreccio, C., Steinmaus, C., Liaw, J., Bates, M., and Smith, A. H. (2010). Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology. 21, 103-108.
320. Yuan, Y., Marshall, G., Ferreccio, C., Steinmaus, C., Selvin, S., Liaw, J., Bates, M. N., and Smith, A. H. (2007). Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am. J. Epidemiol. 166, 1382-1391.
321. Zakharyan, R. A., Ayala-Fierro, F., Cullen, W. R., Carter, D. M., and Aposhian, H. V. (1999). Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158, 9-15.
322. Zakharyan, R. A., Sampayo-Reyes, A., Healy, S. M., Tsaprailis, G., Board, P. G., Liebler, D. C., and Aposhian, H. V. (2001). Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14, 1051-1057.
323. Zernike, K. (2003). Arsenic Case Is Considered Homicide, Maine Police Say. The New York Times, New York, NY.
324. Zhang, T. D., Chen, C. Q., Wang, Z. G., Wang, Z. Y., Chen, S. J., and Chen, Z. (2001). Arsenic trioxide, a therapeutic agent for APL. Oncogene 20, 7146-7153.
325. Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., and Waalkes, M. P. (1997). Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U. S. A. 94, 10907-10912.
326. Zhong, C. X., and Mass, M. J. (2001). Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol. Lett. 122, 223-234.
327. Zhu, B., Wang, X., and Li, L. (2010). Human gut microbiome: the second genome of human body. Protein Cell. 1, 718-725.